Lyft, Inc. is rated a Buy with a $28 price target, implying a 16% upside, due to robust growth and undervaluation. Learn more ...

Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...